We just wanted to drop a new post on our website. It’s really worth reading.
New research is clarifying Post-Acute COVID-19 Vaccination Syndrome (PACVS), confirming real, measurable immune changes in many affected individuals. Mantovani et al.'s recent study highlights autoantibodies linked to persistent symptoms after vaccination, helping define PACVS as a biological condition, not just a collection of complaints.
So what’s IMA doing? We’re all over this. With mounting evidence, the Journal of Independent Medicine will publish a special issue called “Treating Post-Vaccine Complications.” They invite research on PACVS mechanisms, outcomes, therapies, and diagnostics by December 31, 2025, aiming for open access and global impact.
Each new finding brings us closer to acknowledging, treating, and supporting PACVS patients. If you have further research, consider submitting it to advance solutions for all.
Just thought this edging closer to real answers is such good news.